IGKV1D-22 and myocardial infarction: We have previously shown that short-term S100A8/A9 blockade has potent immunomodulatory effects in MI by amplifying anti-apoptotic pathways, inhibiting myocardial damage, and promoting efficient repair and recovery [8, 14].